First Stage Investor

New Recommendation: 20/20 GeneSystems

New Recommendation: 20/20 GeneSystems
By Andy Gordon
Date December 11, 2017
Share
Deal Details Security Type: Preferred Stock Round Size: Up to $1.07 million Price per Share: $3.26 Valuation cap: $23 million Deadline: Midnight (PT) on Thursday, December 14 Investment portal: MicroVentures Liquidation preference: Pari passu with other series of preferred stock and senior to the common…
Early Investing

First Stage Investor

Sign up to view this First Stage Investor article

Become a smarter investor! Discover new investment opportunities and get the latest market research, trends and analysis in startups, crypto and cannabis.

Sign up today

Top Posts on Early Investing

New Pick: A Crypto With a Proven Vision

This month’s crypto recommendation is highly unusual — at least for us. Today I’m recommending a coin that’s already part of the Crypto Asset Strategies

Startup Insider: All About Options With Jeff Bishop

We love talking about startups at Early Investing. But we rarely talk about a different type of investing: options. And if there’s one person who knows options, it’s…

Behind the Pick: A RAD Crypto for Your Portfolio

Radicle — the latest addition to the Crypto Asset Strategies portfolio — is a unique recommendation for us. It’s run by a decentralized autonomous…